Neutral endopeptidase and alcohol consumption, experiments in neutral endopeptidase-deficient mice

European Journal of Pharmacology

Volumn 397, Issue 2-3, 2000, Pages 327-334

  Siems, Wolf Eberhard ^a   Maul, Bjoern ^a   Krause, Winfried ^a   Gerard, Craig ^b   Hauser, Kurt F ^c   Hersh, Louis B ^d   Fischer, Hanspeter S ^e   Zernig, Gerald ^e   Saria, Alois ^e  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e Neurochemistry Unit   (Austria)

Author keywords

Alcohol consumption; Angiotensin converting enzyme; Enkephalin; Enkephalin degrading peptidases; Enkephalinase; Knockout mouse; Neutral endopeptidase; Opioid

Indexed keywords

ALCOHOL; DIPEPTIDYL CARBOXYPEPTIDASE; ENKEPHALIN; MEMBRANE METALLOENDOPEPTIDASE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BRAIN LEVEL; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE TARGETING; KNOCKOUT MOUSE; MALE; MOTIVATION; MOUSE; PRIORITY JOURNAL;

ALCOHOL DRINKING; ANIMALS; ANTIGENS, CD13; AUDITORY CORTEX; BRAIN; CEREBRAL CORTEX; CORPUS STRIATUM; ENKEPHALIN, LEUCINE; GENOTYPE; HIPPOCAMPUS; MALE; MEMBRANES; MESENCEPHALON; MICE; MICE, KNOCKOUT; NEPRILYSIN; OLFACTORY BULB; PEPTIDYL-DIPEPTIDASE A; THALAMUS;

EID: 0034595580     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00222-3     Document Type: Article

References (40)

1. Beliaev N.A., Balakireva N.N., Bursov O.S., Panchenko L.F. Vliianie etanola na enkefalinergicheskuiu opioidnuiu sistemu mozga krys. Biokhimiya. 49:1984;1425-1430.
2. Blum K., Trachtenberg M.C., Elliott C.E., Dingler M.L., Sexton R.L., Samuels A.I., Cataldie L. Enkephalinase inhibition and precursor amine acid loading improves inpatient treatment of alcohol and polydrug abusers: double-blind placebo-controlled study of the nutritional adjunct SAAVE. Alcohol. 5:1988;481-493.
3. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Fitts D.A. Angiotensin and captopril increase alcohol intake. Pharmacol. Biochem. Behav. 45:1993;35-43.
5. Frette C., Pezet S., El-Nabout R.A., Bertrand J.P., Pham Q.T., Kauffmann F., Lafuma C. Relationship of serum neutral endopeptidase E.C. 3.4.24.11 activity to alcohol consumption. Alcohol. Clin. Exp. Res. 22:1998;1405-1408.
6. George S.R., Roldan L., Lui A., Naranjo C.A. Endogenous opioids are involved in the genetically determined high preference for ethanol consumption. Alcohol. Clin. Exp. Res. 15:1991;668-672.
7. Grupp L.A. Effects of angiotensin II and an angiotensin converting inhibitor on alcohol intake in P and NP rats. Pharmacol. Biochem. Behav. 41:1992;105-108.
8. Grupp L.A., Chow S.Y. Time-dependent effect of the angiotensin converting enzyme inhibitor, abutapril, on voluntary intake in the rat. Alcohol Alcohol. 27:1992;267-271.
9. Grupp L.A., Perlanski E., Stewart R.B. Regulation of alcohol consumption by renin-angiotensin system: a review of recent findings and a possible mechanism of action. Neurosci. Biobehav. Rev. 15:1991;265-275.
10. Heder G., Melzig M., Siems W.E. Tyrosine splitting aminopeptidases on cultivated anterior hypophyseal and vascular endothelial cells. Pharmazie. 47:1992;226-228.
11. Hersh L.B., AbouKhair N., Watson S. Immunohistochemical localization of amino peptidase M in rat brain. Peptides. 8:1987;523-532.
12. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology. 129:1997;99-111.
13. Hubbell C.L., Czirr S.A., Reid L.D. Persistence and specifity of small doses of morphine on intake of alcoholic beverages. Alcohol. 4:1987;149-156.
14. Hulme E.C. Receptor preparations for binding studies. Hulme E.C.et al. Receptor-Ligand Interactions, a Practical Approach. 1992;IRL Press.
15. 7 and substance P (1-11) in the brain of mice with different levels of ethanol consumption. Biul. Eksp. Biol. Med. 116:1993;177-178.
16. Konkoy C.S., Davis T.P. Ectoenzymes as sites of peptide regulation. Trends Pharmacol. Sci. 17:1996;288-294.
17. Lu B., Gerard N.P., Kolakowski L.F. Jr., Bozza M., Zurakowski D., Finco O., Carroll M.C., Gerard C. Neutral endopeptidase modulation of septic shock. J. Exp. Med. 181:1995;2271-2275.
18. Lu B., Figini M., Emanueli C., Geppetti P., Grady E.F., Gerard N.P., Ansell J., Payan D.G., Gerard C., Bunnett N. The control of microvascular permeability and blood pressure by neutral endopeptidase. Nature-Med. 3:1997;904-907.
19. Ng G.Y., O'Dowd B.F., George S.R. Genotypic differences in mesolimbic enkephalin gene expression in DBA/2J and C57BL/6J inbred mice. Eur. J. Pharmacol. 311:1996;45-64.
20. Panchenko L.F., Brusov O.S., Beliaev N.A. Issledovanoe mekhanisma destviia etanola na aktivnost' enkefalinazy A mozga krys. Biul. Eksp Biol. Med. 97:1984;691-692.
21. Popov N., Pohle W., Lossner S., Schulzeck S., Schmidt S., Ott T., Matthies H. Regional distribution of RNA and protein radioactivity in the rat brain after intraventricular application of labeled precursors. Acta Biol. Med. Ger. 31:1973;51-62.
22. Reid L.D., Hunter G.A. Morphine and naloxone modulate intake of ethanol. Alcohol. 1:1984;33-37.
23. Sandi C., Borrell J., Guaza C. Administration of leu-enkepahalin impairs the acquisition of preference for ethanol. Psychopharmacology. 100:1990;350-354.
24. Sandi C., Borrell J., Guaza C. D-Ala2-Met5-enkephalinamide impairs the acquisition of ethanol preference without influencing sucrose preference. Physiol. Behav. 48:1990;435-439.
25. Saria A., Hauser K.F., Traurig H.H., Turbek C.S., Hersh L., Gerard C. Opioid related changes in nociceptive threshold and in tissue levels of enkephalins after target disruption of the gene for neutral endopeptidase (EC 3.4.24.11) in mice. Neurosci. Lett. 234:1997;27-30.
26. Saria A., Fischer H.S., Zernig G. Leu-enkephalins outflow in striatal slices of natural endopeptidase knockout mice. Reg. Pept. 80:1999;107. (Abstract).
27. Schulz R., Sakane Y., Berry C., Ghai R. Characterisation of neutral endopeptidase 3.4.24.11 (NEP) in the kidney: comparison between normotensive, genetically hypertensive and experimentally hypertensive rats. J. Enzyme Inhib. 4:1991;347-358.
28. Siems W.-E., Heder G., Komissarowa N.W. Verfahren zur Bestimmung des Angiotensin-Convertig Enzyms. Z. Med. Laboratoriumdiagn. 26:1985;232-235.
29. Siems W.-E., Zipper J., Winkler A., Rottmann M., Heder G., Melzig M.F., Toth G., Hyytiä P. Alcoholism influences opioid hydrolyzing peptidases in rat brain. Alcohol Alcohol. 32s:1997;360. (Abstract).
30. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. 89:1992;2046-2050.
31. Stromberg M.F., Meister S.C., Volpicelli J.R., Ulm R.R. Low doses of morphine and the consumption of a sweetened ethanol solution: differential effects on acquisition and maintenance. Alcohol. 14:1997;463-468.
32. Szczepanska R., Grupp L.A. Bestatin, an aminopeptidase B inhibitor, selectively reduces alcohol intake in rats. Alcohol. Clin. Exp. Res. 17:1993;434-437.
33. Szczepanska R., Harding S., Grupp L.A. Effect of bestatin, an aminopeptidase inhibitor, on alcohol intake in alcohol-preferring P rats. Alcohol. Clin. Exp. Res. 20:1996;561-565.
34. Szczepanska R., Harding S., Grupp L.A. Characterization of the decline in alcohol consumption by aminopeptidase inhibition. Drug Alcohol Depend. 43:1996;133-141.
35. Thiele T.E., Marsh D.J., Ste. Marie L., Bernstein I.L., Palmiter R.D. Ethanol consumption and resistance are inversely related to neuropeptide Y. Nature. 396:1998;366-369.
36. Tsushima H., Mori M., Matsuda T. Antidiuretic effects of methionine-enkephalin and 2-D-alanine-5-methionine-enkephalinamide microinjected into the hypothalamic supraoptic and paraventricular nuclei in a water-loaded and ethanol-anesthetized rat. Jpn. J. Pharmacol. 42:1986;507-515.
37. Turner A.J. Neuropeptide signaling and cell-surface peptidases. Nishizuka The Biology and Medicine of Signal Transduction. 1990;467-471 Raven Press, New York.
38. Turner A.J., Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J. 11:1997;355-364.
39. Waksman G., Hamel E., Fournie-Zaluski M.C., Roques B.P. Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain. Proc. Natl. Acad. Sci. U. S. A. 83:1986;1523-1527.
40. Winkler A., Buzas B., Siems W.E., Heder G., Cox B.M. Effect of ethanol drinking on the gene expression of opioid receptors, enkephalinase, and angiotensin-converting enzyme in two inbred mice strains. Alcohol. Clin. Exper. Res. 22:1998;1262-1271.